IN2013MU02852A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02852A
IN2013MU02852A IN2852MU2013A IN2013MU02852A IN 2013MU02852 A IN2013MU02852 A IN 2013MU02852A IN 2852MU2013 A IN2852MU2013 A IN 2852MU2013A IN 2013MU02852 A IN2013MU02852 A IN 2013MU02852A
Authority
IN
India
Prior art keywords
naloxone
buprenorphine
opioid
patient
treatment
Prior art date
Application number
Other languages
English (en)
Inventor
Rajen Dhirubhai Shah
Milind Sakharam Bagul
Original Assignee
Raptim Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raptim Res Ltd filed Critical Raptim Res Ltd
Priority to IN2852MU2013 priority Critical patent/IN2013MU02852A/en
Publication of IN2013MU02852A publication Critical patent/IN2013MU02852A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN2852MU2013 2013-09-02 2013-09-02 IN2013MU02852A (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2852MU2013 IN2013MU02852A (enrdf_load_stackoverflow) 2013-09-02 2013-09-02

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2852MU2013 IN2013MU02852A (enrdf_load_stackoverflow) 2013-09-02 2013-09-02

Publications (1)

Publication Number Publication Date
IN2013MU02852A true IN2013MU02852A (enrdf_load_stackoverflow) 2015-07-10

Family

ID=54396132

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2852MU2013 IN2013MU02852A (enrdf_load_stackoverflow) 2013-09-02 2013-09-02

Country Status (1)

Country Link
IN (1) IN2013MU02852A (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
PT3031826T (pt) Composição farmacêutica para o tratamento e/ou a prevenção do cancro
IN2014DN10670A (enrdf_load_stackoverflow)
GB201320723D0 (en) Composition and methods of treatment
SG11201502752VA (en) Pharmaceutical compositions comprising hydromorphone and naloxone
IL239851B (en) Methods and compositions for treating diseases that act to remove myelin
MX2016011744A (es) Soluciones de buprenorfina de liberacion sostenida.
SI3223906T1 (sl) Postopki in sestavki za povečanje delovanja opioidnih analgetikov z uporabo alkaloidov iz iboge
SG11201509782TA (en) Compositions and methods for the treatment of diabetes and pre-diabetes
EP3061452A4 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
MX2015012650A (es) Metodos para el tratamiento de angioedema mediado receptores debradicinina b2.
MX2015008813A (es) Composiciones y metodos para contrarrestar la inhibicion del factor xa.
ZA201408055B (en) Compositions and methods for the treatment of local pain
IN2014DN09238A (enrdf_load_stackoverflow)
PH12016500666A1 (en) Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
EP3004114A4 (en) Morphan and morphinan analogues, and methods of use
PL2968478T3 (pl) Kompozycje i sposoby do leczenia karboksyhemoglobinemii
MX368870B (es) Uso de un antagonista de receptores de opioides con actividad kappa y vortioxetina para el tratamiento de trastorno depresivo con características melancólicas.
EP3060566A4 (en) Compounds for use in prevention and treatment of neurodegenerative diseases and pain
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
IL235272B (en) Alfentanil preparation for the treatment of acute pain
EP3052493A4 (en) Enhanced treatment regimens using pi3k inhibitors
EP2968247A4 (en) Taste masking of anesthetics and analgesics
IN2013MU01111A (enrdf_load_stackoverflow)
TR201803744T4 (tr) Skleroderma tedavisinde kullanım için naltrekson içeren bileşimler.